Mckesson corporation (MCK)
Income statement / Yearly
Mar'20Mar'19Mar'18Mar'17Mar'16Mar'15Mar'14Mar'13Mar'12Mar'11Mar'10Mar'09Mar'08
Revenues

231,051

214,319

208,357

198,533

190,884

179,045

137,392

122,196

122,321

112,084

108,702

106,632

101,703

Cost of Sales

219,028

202,565

197,173

187,262

179,468

167,634

129,040

115,315

115,919

106,114

103,026

101,254

96,694

Gross Profit

12,023

11,754

11,184

11,271

11,416

11,411

8,352

6,881

6,402

5,970

5,676

5,378

5,009

Selling, distribution and administrative expenses

9,168

8,403

8,138

7,447

7,379

7,901

5,388

4,110

3,727

-

-

-

-

Selling

-

-

-

-

-

-

-

-

-

767

746

743

744

Distribution

-

-

-

-

-

-

-

-

-

920

882

943

886

Research and development

96

71

125

341

392

392

457

433

402

407

376

364

347

Restructuring charges

-

-

-

-

-

0

0

-

-

-

-

-

-

Goodwill, Impairment Loss

2

1,797

1,700

290

0

0

-

-

-

-

-

-

-

Restructuring, impairment and related charges

268

597

567

-

-

-

-

-

-

-

-

-

-

Restructuring, Impairment and Related Charges

-

-

-

18

203

-

-

-

-

-

-

-

-

Administrative

-

-

-

-

-

-

-

-

-

1,842

1,684

1,639

1,559

Claim and litigation charges

-

-

-

-

-

150

68

72

149

213

20

-493

-5

Gain (Loss) on Disposition of Business

0

0

37

0

-

0

-

-

-

-

-

-

-

Gain on business combination

-

-

-

-

-

-

-

81

0

0

-

-

-

Total Operating Expenses

9,534

10,868

10,422

4,149

7,871

8,443

5,913

4,534

4,278

4,149

3,668

4,182

3,531

Operating Income

2,489

886

762

7,122

3,545

2,968

2,439

2,347

2,124

1,821

2,008

1,196

1,478

Other Income, Net

12

182

130

77

58

63

32

34

20

36

43

12

121

Equity Earnings and Charges from Investment in Change Healthcare Joint Venture

-1,108

-194

-248

-

-

-

-

-

-

-

-

-

-

Loss on Debt Extinguishment

0

0

-122

0

0

-

-

-

-

-

-

-

-

Interest Expense

249

264

283

-

-

-

-

-

-

-

-

-

-

Impairment of an Equity Investment

-

-

-

-

-

-

-

191

0

0

-

-

-

Interest and Debt Expense

-

-

-

308

353

374

300

240

251

222

187

144

142

Income from Continuing Operations Before Income Taxes

1,144

610

239

6,891

3,250

2,657

2,171

1,950

1,893

1,635

1,864

1,064

1,457

Income Tax (Expense) Benefit

18

356

-53

1,614

908

815

757

587

514

505

601

241

468

Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest

1,126

254

292

5,277

2,342

1,842

1,414

1,363

1,379

1,130

1,263

823

989

Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest

-6

1

5

-124

-32

-299

-156

-25

24

-

-

-

1

Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

1,120

255

297

5,153

2,310

1,543

1,258

1,338

1,403

-

-

-

-

Net Income (Loss) Attributable to Noncontrolling Interest

220

221

230

83

52

67

-5

0

0

-

-

-

-

Discontinued Operation  gain on sale, net of tax

-

-

-

-

-

-

-

-

-

72

0

-

-

Net Income Attributable to McKesson Corporation

900

34

67

5,070

2,258

1,476

1,263

1,338

1,403

1,202

1,263

823

990

Earnings Per Share [Abstract]
Earnings Per Share, Diluted [Abstract]
Continuing operations (in dollars per share)

4.99

0.17

0.30

23.28

9.84

7.54

6.08

5.69

5.49

4.29

4.62

2.95

3.32

Discontinued operations (in dollars per share)

-0.04

0.00

0.02

-0.55

-0.14

-1.27

-0.67

-0.10

0.10

0.28

0.00

-

0.00

Total (in dollars per share)

4.95

0.17

0.32

22.73

9.70

6.27

5.41

5.59

5.59

4.57

4.62

2.95

3.32

Basic
Continuing operations (in dollars per share)

5.01

0.17

0.30

23.50

9.96

7.66

6.19

5.81

5.60

4.37

4.70

2.99

3.40

Discontinued operations (in dollars per share)

-0.03

0.00

0.02

-0.55

-0.14

-1.29

-0.68

-0.10

0.10

0.28

0.00

-

0.00

Total (in dollars per share)

4.98

0.17

0.32

22.95

9.82

6.37

5.51

5.71

5.70

4.65

4.70

2.99

3.40

Weighted Average Number of Shares Outstanding, Diluted [Abstract]
Weighted Average Number of Shares Outstanding, Diluted

182

197

209

223

233

235

233

239

251

263

273

279

298

Basic (in shares)

181

196

208

221

230

232

229

235

246

258

269

275

291

Businesses
Gain (Loss) on Disposition of Business

0

0

109

-

-

-

-

-

-

-

-

-

-

Healthcare Technology Net Asset Exchange
Gain (Loss) on Disposition of Business

0

0

37

3,947

-

-

-

-

-

-

-

-

-

Change Healthcare
Income (Loss) from Equity Method Investments

-

-

-

0

-

-

-

-

-

-

-

-

-